Vimarsana
Biggest News Aggregation in the World

Page 6 - Integrative Screening Process News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Integrative Screening Process. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Integrative Screening Process Today - Breaking & Trending Today

IRLAB Extends CEO Appointment - Vimarsana News

IRLAB Extends CEO Appointment

GOTHENBURG, SWEDEN / ACCESSWIRE / December 27, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, December 27, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the appointment of Gunnar Ol...

IRLAB Increases its Liquidity with a Loan Facility of Up to SEK 55 ... - Vimarsana News

IRLAB Increases its Liquidity with a Loan Facility of Up to SEK 55 ...

IRLAB Increases its Liquidity with a Loan Facility of Up to SEK 55 ...

IRLAB Increases its Liquidity with a Loan Facility of Up to SEK 55 Million that Extends Financial Ru - Vimarsana News

IRLAB Increases its Liquidity with a Loan Facility of Up to SEK 55 Million that Extends Financial Ru

GOTHENBURG, SWEDEN / ACCESSWIRE / December 22, 2023 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)(Nasdaq Stockholm:IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company has entered into a loan agreement of up to SEK 55 million issued by Formue Nord F...

IRLAB's Drug Candidate IRL757 is Phase I Ready - Vimarsana News

IRLAB's Drug Candidate IRL757 is Phase I Ready

GOTHENBURG, SWEDEN / ACCESSWIRE / December 21, 2023 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) Gothenburg, Sweden, December 21, 2023 - IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A), a company discovering and developing novel treatments for Parkinson's disease, today announced that the company's drug candidate...

IRLAB's Drug Candidate IRL757 is Phase I Ready 2023-12-21 - Vimarsana News

IRLAB's Drug Candidate IRL757 is Phase I Ready 2023-12-21

IRLAB’s Drug Candidate IRL757 is Phase I Ready